Spatio-temporal development of axonopathy in canine intervertebral disc disease as a translational large animal model for nonexperimental spinal cord injury

Brain Pathol. 2013 Jan;23(1):82-99. doi: 10.1111/j.1750-3639.2012.00617.x. Epub 2012 Aug 14.

Abstract

Spinal cord injury (SCI) represents a devastating central nervous system disease that still lacks sufficient therapies. Here, dogs are increasingly recognized as a preclinical animal model for the development of future therapies. The aim of this study was a detailed characterization of axonopathy in canine intervertebral disc disease, which produces a mixed contusive and compressive injury and functions as a spontaneous translational animal model for human SCI. The results revealed an early occurrence of ultrastructurally distinct axonal swelling. Immunohistochemically, enhanced axonal expression of β-amyloid precursor protein, non-phosphorylated neurofilament (n-NF) and growth-associated protein-43 was detected in the epicenter during acute canine SCI. Indicative of a progressive axonopathy, these changes showed a cranial and caudally accentuated spatial progression in the subacute disease phase. In canine spinal cord slice cultures, immunoreactivity of axons was confined to n-NF. Real-time quantitative polymerase chain reaction of naturally traumatized tissue and slice cultures revealed a temporally distinct dysregulation of the matrix metalloproteinases (MMP)-2 and MMP-9 with a dominating expression of the latter. Contrasting to early axonopathy, diminished myelin basic protein immunoreactivity and phagocytosis were delayed. The results present a basis for assessing new therapies in the canine animal model for translational research that might allow partial extrapolation to human SCI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axons / pathology
  • Disease Models, Animal
  • Dogs
  • Female
  • GAP-43 Protein / metabolism
  • GAP-43 Protein / ultrastructure
  • Gene Expression Regulation / physiology
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Hypoxanthine Phosphoribosyltransferase / metabolism
  • Intervertebral Disc Degeneration / pathology*
  • Intervertebral Disc Displacement / pathology*
  • Macrophages / pathology
  • Male
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / metabolism
  • Microglia / pathology
  • Microscopy, Electron, Transmission
  • Microscopy, Immunoelectron
  • Myelin Basic Protein / genetics
  • Myelin Basic Protein / metabolism
  • Neurofilament Proteins / metabolism
  • Organ Culture Techniques
  • Peptide Elongation Factor 1 / genetics
  • Peptide Elongation Factor 1 / metabolism
  • Phagocytes / pathology
  • RNA, Messenger / metabolism
  • Spinal Cord / metabolism*
  • Spinal Cord / pathology
  • Spinal Cord / ultrastructure
  • Spinal Cord Injuries / pathology*
  • Spinal Cord Injuries / veterinary
  • Statistics, Nonparametric

Substances

  • GAP-43 Protein
  • Myelin Basic Protein
  • Neurofilament Proteins
  • Peptide Elongation Factor 1
  • RNA, Messenger
  • Hypoxanthine Phosphoribosyltransferase
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9

Supplementary concepts

  • Intervertebral disc disease